Search Results - "Exter, P.L. den"

Refine Results
  1. 1

    The post-PE syndrome: a new concept for chronic complications of pulmonary embolism by Klok, F.A, van der Hulle, T, den Exter, P.L, Lankeit, M, Huisman, M.V, Konstantinides, S

    Published in Blood reviews (01-11-2014)
    “…Abstract Long-term follow-up studies have consistently demonstrated that after an episode of acute pulmonary embolism (PE), half of patients report functional…”
    Get full text
    Journal Article
  2. 2

    Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation by van Nieuwkoop, C, den Exter, P.L, Elzevier, H.W, den Hartigh, J, van Dissel, J.T

    “…Abstract Clean intermittent catheterisation (CIC) of the bladder is used to imitate normal bladder emptying in patients with bladder dysfunction. CIC is…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism by Wilts, I.T, Le Gal, G, Den Exter, P.L, Van Es, J, Carrier, M, Planquette, B, Büller, H.R, Righini, M, Huisman, M.V, Kamphuisen, P.W

    Published in Thrombosis research (01-04-2017)
    “…Abstract Background Cancer patients frequently present with suspected pulmonary embolism (PE). The D-dimer (DD) test is less useful in excluding PE in cancer…”
    Get full text
    Journal Article
  5. 5

    Long-term clinical course of acute pulmonary embolism by den Exter, P.L, van der Hulle, T, Lankeit, M, Huisman, M.V, Klok, F.A

    Published in Blood reviews (01-07-2013)
    “…Abstract The long-term clinical course of acute pulmonary embolism (PE) is complicated by high rates of serious adverse events, both before and after cessation…”
    Get full text
    Journal Article
  6. 6

    PO-29 - Age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy by Wilts, I.T, Le Gal, G, den Exter, P.L, van Es, J, Carrier, M, Planquette, B, Büller, H.R, Righini, M, Huisman, M.V, Kamphuisen, P.W

    Published in Thrombosis research (01-04-2016)
    “…Introduction Patients with cancer frequently present with suspected pulmonary embolism (PE). The D-dimer test is less useful to rule out PE in cancer patients…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis by van Es, N, van der Hulle, T, van Es, J, den Exter, P.L, Douma, R.A, Goekoop, R.J, Mos, I.C.M, Garcia, J.G, Kamphuisen, P.W, Huisman, M.V, Klok, F.A, Büller, H.R, Bossuyt, P.M

    Published in Thrombosis research (01-04-2016)
    “…Introduction Among patients with clinically suspected pulmonary embolism (PE), imaging and anticoagulant treatment can be safely withheld in approximately…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis by Hulle, T., Kooiman, J., Exter, P. L., Dekkers, O. M., Klok, F. A., Huisman, M. V.

    Published in Journal of thrombosis and haemostasis (01-03-2014)
    “…Summary Introduction New direct oral anticoagulants (NOACs) constitute a novel treatment option for acute venous thromboembolism (VTE), with practical…”
    Get full text
    Journal Article
  12. 12

    Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolism by Hulle, T., Exter, P. L., Kooiman, J., Hoeven, J. J. M., Huisman, M. V., Klok, F. A.

    Published in Journal of thrombosis and haemostasis (01-07-2014)
    “…Summary Introduction Treatment of acute venous thromboembolism (VTE) in cancer patients is challenging, owing to a high risk of recurrent VTE and bleeding…”
    Get full text
    Journal Article
  13. 13

    Differential effect of anticoagulant treatment on vascular morphology in patients with acute pulmonary embolism by Braams, N.J, Boon, G.J.A.M, Den Exter, P.L, Kroft, L.J.M, Beenen, L.F.M, Huisman, M.V, Vonk Noordegraaf, A, Bogaard, H.J, De Man, F.S, Klok, F.A, Meijboom, L.J

    Published in European heart journal (01-11-2020)
    “…Abstract Introduction Chronic thromboembolic pulmonary hypertension (CTEPH) is described as one of the most severe consequence of acute pulmonary embolism…”
    Get full text
    Journal Article
  14. 14

    Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes by van der Horst, S.F.B., Martens, E.S.L., den Exter, P.L., Bos, M.H.A., van Mens, T.E., Huisman, M.V., Klok, F.A.

    Published in Thrombosis research (01-08-2023)
    “…Idarucizumab has been approved to reverse the anticoagulant effect of dabigatran. However, there is little knowledge of the effectiveness and safety of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The original and simplified Wells rules and age‐adjusted D‐dimer testing to rule out pulmonary embolism: an individual patient data meta‐analysis by Es, N., Kraaijpoel, N., Klok, F. A., Huisman, M. V., Den Exter, P. L., Mos, I. C. M., Galipienzo, J., Büller, H. R., Bossuyt, P. M.

    Published in Journal of thrombosis and haemostasis (01-04-2017)
    “…Essentials Evidence for the simplified Wells rule in ruling out acute pulmonary embolism (PE) is scarce. This was a post‐hoc analysis on data from 6 studies…”
    Get full text
    Journal Article
  17. 17

    Continuation of low‐molecular‐weight heparin treatment for cancer‐related venous thromboembolism: a prospective cohort study in daily clinical practice by Wall, S. J., Klok, F. A., Exter, P. L., Barrios, D., Morillo, R., Cannegieter, S. C., Jimenez, D., Huisman, M. V.

    Published in Journal of thrombosis and haemostasis (01-01-2017)
    “…Essentials Low‐molecular‐weight heparin (LMWH) injections for venous thromboembolism (VTE) may be burdensome. Patients with active cancer and confirmed VTE…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20